HCP
ONC icon

Hexagon Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

Hexagon Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36
Closed -$9.8K – 1817
2025
Q1 		$9.8K Sell
36
-23
-39% -$5.38K ﹤0.01% 987
2024
Q4 		$10.9K Buy
+59
New +$12.1K ﹤0.01% 983

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hexagon Capital Partners's ONC Position: Q2 2025 in Review

Hexagon Capital Partners sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 36 shares — an estimated $9.8K sold.

Hexagon Capital Partners first reported a position in ONC in Q4 2024 and held it in 2 quarters. The position peaked at $10.9K in Q4 2024. 245 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Hexagon Capital Partners reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 36 BeOne Medicines Ltd shares in Q2 2025, an estimated $9.8K.
  • Hexagon Capital Partners first reported a position in BeOne Medicines Ltd in Q4 2024 and held it in 2 quarters.
  • Hexagon Capital Partners's BeOne Medicines Ltd position peaked at $10.9K in Q4 2024.
  • 245 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.